NUDT21 knockdown inhibits proliferation and promotes apoptosis of pancreatic ductal adenocarcinoma through EIF2 signaling

Yan-Song Zheng,Ming-Liu Chen,Wen-di Lei,Shan-Lan Zhu,Xiao-Qing You,Yingchun Liu,Yan-song Zheng,Ming-liu Chen,Shan-lan Zhu,Xiao-qing You
DOI: https://doi.org/10.1016/j.yexcr.2020.112182
IF: 4.145
2020-10-01
Experimental Cell Research
Abstract:<p>The NUDT family is thought to play an important role in cancer growth and progression. However, the clinicopathologic significance and potential role of nucleotide diphosphate-linked X-component motif 21, NM_007006 (NUDT21) in pancreatic ductal adenocarcinoma (PDAC) remains largely unknown. In this study, we observed that NUDT21 was frequently up-expressed in PDAC. Clinical data revealed that its level positively correlated with poor survival of patients with PDAC. We found that knockdown of NUDT21 significantly inhibited cell proliferation and promoted apoptosis both in vitro and in vivo. Screening by microarray analysis and <a href="https://www.baidu.com/link?url=k4znruIaDUImoW4-jqDR4D4dO4MkHXR2HwxG23iYVDcOWjDnfWChaf8g0wF7mhRMABq3FNUNCPlMYRDcO0PusrSVtnEdFYcsrQrEr8Hj_ja">verifying</a> by Western blot, we found that the EIF2 signaling pathway represented the main molecular mechanism underlying the effects of NUDT21 knockdown in PANC-1 cells, and PKR, HSPA5, EIF4E and DDIT3 may be its target genes. Thus, our results revealed for the first time that NUDT21, a valuable marker of PDAC prognosis, promotes tumor proliferation, inhibits cells apoptosis and might represent a potential target for gene-based therapy.</p>
oncology,cell biology
What problem does this paper attempt to address?